Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-12

FDA Approved: RANOLAZINE — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved the original ANDA for Ranolazine from Lifestar Pharma LLC, authorizing a generic version of the anti-anginal medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)